Evidence map›Paper›PMID 37745652›Full record

ArticleFrontiers in neurology2023

Non-invasive and accurate risk evaluation of cerebrovascular disease using retinal fundus photo based on deep learning.

Lin An, Jia Qin, Weili Jiang, Penghao Luo, Xiaoyan Luo, Yuzheng Lai, Mei Jin

Abstract read
In one paragraph

Article in Frontiers in neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lin AnGuangdong Weiren Meditech Co., Ltd, Foshan, Guangdong, China.
Jia QinGuangdong Weiren Meditech Co., Ltd, Foshan, Guangdong, China.
Weili JiangFoshan Weizhi Meditech Co., Ltd, Foshan, Guangdong, China.
Penghao LuoFoshan Weizhi Meditech Co., Ltd, Foshan, Guangdong, China.
Xiaoyan LuoDepartment of Ophthalmology, Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine, Foshan, Guangdong, China.
Yuzheng LaiDepartment of Neurology, Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine, Foshan, Guangdong, China.
Mei JinDepartment of Ophthalmology, Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine, Foshan, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cerebrovascular disease (CeVD) is a prominent contributor to global mortality and profound disability. Extensive research has unveiled a connection between CeVD and retinal microvascular abnormalities. Nonetheless, manual analysis of fundus images remains a laborious and time-consuming task. Consequently, our objective is to develop a risk prediction model that utilizes retinal fundus photo to noninvasively and accurately assess cerebrovascular risks. Materials and methods: To leverage retinal fundus photo for CeVD risk evaluation, we proposed a novel model called Efficient Attention which combines the convolutional neural network with attention mechanism. This combination aims to reinforce the salient features present in fundus photos, consequently improving the accuracy and effectiveness of cerebrovascular risk assessment. Result: Our proposed model demonstrates notable advancements compared to the conventional ResNet and Efficient-Net architectures. The accuracy (ACC) of our model is 0.834 ± 0.03, surpassing Efficient-Net by a margin of 3.6%. Additionally, our model exhibits an improved area under the receiver operating characteristic curve (AUC) of 0.904 ± 0.02, surpassing other methods by a margin of 2.2%. Conclusion: This paper provides compelling evidence that Efficient-Attention methods can serve as effective and accurate tool for cerebrovascular risk. The results of the study strongly support the notion that retinal fundus photo holds great potential as a reliable predictor of CeVD, which offers a noninvasive, convenient and low-cost solution for large scale screening of CeVD.

Indexed as

artificial intelligenceattentioncerebrovascular diseasedeep learningstroke

Identifiers

PMID37745652
PMCPMC10513168

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.